| Overall N(473) a N(%) | Relapse (Yes = 240) a n(%) | Relapse (No = 233) a n(%) |
---|---|---|---|
Socio-demographic | Â | Â | Â |
 Age (years), mean (SD) | 46.7 (11.2) | 46.4 (11.1) | 47.1 (11.4) |
 Gender/sexual orientation | |||
   Women | 75 (16.2) | 38 (16.1) | 37 (16.3) |
   Male heterosexual | 79 (17.1) | 35 (14.8) | 44 (19.4) |
   MSM | 309 (66.7) | 163 (69.1) | 146 (64.3) |
 Race/ethnicity | |||
   White | 231 (49.3) | 120 (50.2) | 111 (48.3) |
   African American | 238 (50.7) | 119 (49.8) | 119 (51.7) |
Clinical/medical | |||
 Length in care (years) mean (SD) | 8.8 (4.74) | 9.14 (4.62) | 8.54 (4.85) |
 Adherent to ART | 66 (15.6) | 34 (16.4) | 32 (14.7) |
 Health Insurance | |||
   Private | 152 (32.1) | 78 (36.2) | 74 (31.8) |
   Public | 126 (26.6) | 64 (26.7) | 62 (26.6) |
   Uninsured | 195 (41.2) | 98 (40.8) | 97 (41.6) |
 Comorbiditiesb | |||
   Cardiovascular | 70 (14.8) | 30 (12.5) | 40 (17.2) |
   Respiratory | 101 (21.4) | 59 (24.6) | 42 (18.0) |
   Metabolic | 71 (15.0) | 32 (13.3) | 39(16.7) |
   Cancer | 34 (7.2) | 21 (8.80) | 13 (5.60) |
 Laboratory parameterc | |||
   Plasma HIV-1 RNA < 200 copies/ml | 386 (81.6) | 190 (79.2) | 196 (84.1) |
 CD4 count (cells/μL) | |||
    < 200 | 49 (10.4) | 20 (8.40) | 29 (12.4) |
    ≥ 200 | 423 (89.6) | 219 (91.6) | 204 (87.6) |
Behavioral and psychologicale | |||
 Depressive symptoms | 97 (20.9) | 58 (24.6) | 39 (17.0) |
 Anxiety symptoms | 130 (28.2) | 80 (34.2) | 50 (22.0) |
 Substance abused | |||
   Never | 65 (13.7) | 33 (13.7) | 32 (13.7) |
   Prior | 177 (37.4) | 91 (37.9) | 86 (36.9) |
   Current | 49 (10.4) | 28 (11.7) | 21 (9.01) |
   Unknown | 182 (38.5) | 88 (36.7) | 94 (40.3) |
 Alcohol abuse | |||
   No risk | 150 (34.6) | 74 (33.6) | 136 (65.1) |
   Low risk | 232 (53.6) | 111 (50.5) | 121 (56.8) |
   At risk | 51 (11.8) | 35 (15.9) | 16 (7.5) |